Conserved and variant epitopes of Plasmodium vivax Duffy ... · 42 Plasmodium vivax is the most widely distri buted human malaria parasite responsible for about 50% of 43 malaria
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as 1
REFERENCES 287 1. Adams, J. H., D. E. Hudson, M. Torii, G. E. Ward, T. E. Wellems, M. Aikawa, and L. H. 288
Miller. 1990. The Duffy receptor family of Plasmodium knowlesi is located within the 289 micronemes of invasive malaria merozoites. Cell 63:141-153. 290 2. Adams, J. H., B. K. Sim, S. A. Dolan, X. Fang, D. C. Kaslow, and L. H. Miller. 1992. A 291 family of erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci U S A 292
89:7085-7089. 293 3. Anders, R. F., P. E. Crewther, S. Edwards, M. Margetts, M. L. Matthew, B. Pollock, and 294
D. Pye. 1998. Immunisation with recombinant AMA-1 protects mice against infection 295 with Plasmodium chabaudi. Vaccine 16:240-247. 296 4. Batchelor, J. D., J. A. Zahm, and N. H. Tolia. 2011. Dimerization of Plasmodium vivax 297 DBP is induced upon receptor binding and drives recognition of DARC. Nat Struct Mol 298 Biol 18:908-914. 299 5. Camus, D., and T. J. Hadley. 1985. A Plasmodium falciparum antigen that binds to host 300 erythrocytes and merozoites. Science 230:553-556. 301 6. Ceravolo, I. P., B. A. Sanchez, T. N. Sousa, B. M. Guerra, I. S. Soares, E. M. Braga, A. M. 302
McHenry, J. H. Adams, C. F. Brito, and L. H. Carvalho. 2009. Naturally acquired 303 inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and 304 allele-specific following a single malaria infection. Clin Exp Immunol 156:502-510. 305 7. Ceravolo, I. P., F. A. Souza-Silva, C. J. Fontes, E. M. Braga, A. P. Madureira, A. U. 306
Krettli, J. M. Souza, C. F. Brito, J. H. Adams, and L. H. Carvalho. 2008. Inhibitory 307 properties of the antibody response to Plasmodium vivax Duffy binding protein in an area 308 with unstable malaria transmission. Scand J Immunol 67:270-278. 309
8. Chitnis, C. E., A. Chaudhuri, R. Horuk, A. O. Pogo, and L. H. Miller. 1996. The domain 310 on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial 311 parasites to erythrocytes. J Exp Med 184:1531-1536. 312 9. Chitnis, C. E., and L. H. Miller. 1994. Identification of the erythrocyte binding domains of 313
Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J 314 Exp Med 180:497-506. 315 10. Chootong, P., F. B. Ntumngia, K. M. VanBuskirk, J. Xainli, J. L. Cole-Tobian, C. O. 316
Campbell, T. S. Fraser, C. L. King, and J. H. Adams. 2010. Mapping epitopes of the 317
Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. 318 Infect Immun 78:1089-1095. 319 11. Cole-Tobian, J., and C. L. King. 2003. Diversity and natural selection in Plasmodium 320
vivax Duffy binding protein gene. Mol Biochem Parasitol 127:121-132. 321 12. Cole-Tobian, J. L., P. Michon, M. Biasor, J. S. Richards, J. G. Beeson, I. Mueller, and C. 322
L. King. 2009. Strain-specific duffy binding protein antibodies correlate with protection 323 against infection with homologous compared to heterologous Plasmodium vivax strains 324 in Papua New Guinean children. Infect Immun 77:4009-4017. 325 13. Coley, A. M., K. Parisi, R. Masciantonio, J. Hoeck, J. L. Casey, V. J. Murphy, K. S. Harris, 326
A. H. Batchelor, R. F. Anders, and M. Foley. 2006. The most polymorphic residue on 327
Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-328 inhibitory antibody. Infect Immun 74:2628-2636. 329 14. Crewther, P. E., M. L. Matthew, R. H. Flegg, and R. F. Anders. 1996. Protective immune 330 responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of 331 strain-specific epitopes. Infect Immun 64:3310-3317. 332
15. Fitch, W. M., J. M. Leiter, X. Q. Li, and P. Palese. 1991. Positive Darwinian evolution in 333 human influenza A viruses. Proc Natl Acad Sci U S A 88:4270-4274. 334 16. Fraser, T. S., S. H. Kappe, D. L. Narum, K. M. VanBuskirk, and J. H. Adams. 2001. 335 Erythrocyte-binding activity of Plasmodium yoelii apical membrane antigen-1 expressed 336 on the surface of transfected COS-7 cells. Mol Biochem Parasitol 117:49-59. 337 17. Grimberg, B. T., R. Udomsangpetch, J. Xainli, A. McHenry, T. Panichakul, J. 338
Sattabongkot, L. Cui, M. Bockarie, C. Chitnis, J. Adams, P. A. Zimmerman, and C. L. 339
King. 2007. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies 340 directed against the Duffy binding protein. PLoS Med 4:e337. 341 18. Haynes, J. D., J. P. Dalton, F. W. Klotz, M. H. McGinniss, T. J. Hadley, D. E. Hudson, and 342
L. H. Miller. 1988. Receptor-like specificity of a Plasmodium knowlesi malarial protein 343 that binds to Duffy antigen ligands on erythrocytes. J Exp Med 167:1873-1881. 344 19. King, C. L., P. Michon, A. R. Shakri, A. Marcotty, D. Stanisic, P. A. Zimmerman, J. L. 345
Cole-Tobian, I. Mueller, and C. E. Chitnis. 2008. Naturally acquired Duffy-binding 346 protein-specific binding inhibitory antibodies confer protection from blood-stage 347
Plasmodium vivax infection. Proc Natl Acad Sci U S A 105:8363-8368. 348 20. Mayer, D. C., J. B. Mu, O. Kaneko, J. Duan, X. Z. Su, and L. H. Miller. 2004. 349 Polymorphism in the Plasmodium falciparum erythrocyte-binding ligand JESEBL/EBA-350 181 alters its receptor specificity. Proc Natl Acad Sci U S A 101:2518-2523. 351 21. Mendis, K., B. J. Sina, P. Marchesini, and R. Carter. 2001. The neglected burden of 352
Plasmodium vivax malaria. Am J Trop Med Hyg 64:97-106. 353 22. Michon, P., T. Fraser, and J. H. Adams. 2000. Naturally acquired and vaccine-elicited 354 antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding 355 protein. Infect Immun 68:3164-3171. 356
23. Michon, P., I. Woolley, E. M. Wood, W. Kastens, P. A. Zimmerman, and J. H. Adams. 357 2001. Duffy-null promoter heterozygosity reduces DARC expression and abrogates 358 adhesion of the P. vivax ligand required for blood-stage infection. FEBS Lett 495:111-359 114. 360 24. Michon, P. A., M. Arevalo-Herrera, T. Fraser, S. Herrera, and J. H. Adams. 1998. 361 Serologic responses to recombinant Plasmodium vivax Duffy binding protein in a 362 Colombian village. Am J Trop Med Hyg 59:597-599. 363 25. Miller, L. H., S. J. Mason, D. F. Clyde, and M. H. McGinniss. 1976. The resistance factor 364 to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 365
295:302-304. 366 26. Ntumngia, F. B., A. M. McHenry, J. W. Barnwell, J. Cole-Tobian, C. L. King, and J. H. 367
Adams. 2009. Genetic variation among Plasmodium vivax isolates adapted to non-human 368 primates and the implication for vaccine development. Am J Trop Med Hyg 80:218-227. 369 27. Singh, S., K. Pandey, R. Chattopadhayay, S. S. Yazdani, A. Lynn, A. Bharadwaj, A. 370
Ranjan, and C. Chitnis. 2001. Biochemical, biophysical, and functional characterization 371 of bacterially expressed and refolded receptor binding domain of Plasmodium vivax 372 duffy-binding protein. J Biol Chem 276:17111-17116. 373 28. Tolia, N. H., E. J. Enemark, B. K. Sim, and L. Joshua-Tor. 2005. Structural basis for the 374 EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. 375 Cell 122:183-193. 376 29. Tran, T. M., A. Moreno, S. S. Yazdani, C. E. Chitnis, J. W. Barnwell, and M. R. Galinski. 377 2005. Detection of a Plasmodium vivax erythrocyte binding protein by flow cytometry. 378 Cytometry A 63:59-66. 379
30. Tsuboi, T., S. H. Kappe, F. al-Yaman, M. D. Prickett, M. Alpers, and J. H. Adams. 1994. 380 Natural variation within the principal adhesion domain of the Plasmodium vivax duffy 381 binding protein. Infect Immun 62:5581-5586. 382 31. VanBuskirk, K. M., J. L. Cole-Tobian, M. Baisor, E. S. Sevova, M. Bockarie, C. L. King, 383
and J. H. Adams. 2004. Antigenic drift in the ligand domain of Plasmodium vivax duffy 384 binding protein confers resistance to inhibitory antibodies. J Infect Dis 190:1556-1562. 385 32. VanBuskirk, K. M., E. Sevova, and J. H. Adams. 2004. Conserved residues in the 386
Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte 387 receptor recognition. Proc Natl Acad Sci U S A 101:15754-15759. 388 33. Welch, S. G., I. A. McGregor, and K. Williams. 1977. The Duffy blood group and malaria 389 prevalence in Gambian West Africans. Trans R Soc Trop Med Hyg 71:295-296. 390 34. Wickramarachchi, T., Y. S. Devi, A. Mohmmed, and V. S. Chauhan. 2008. Identification 391 and characterization of a novel Plasmodium falciparum merozoite apical protein involved 392 in erythrocyte binding and invasion. PLoS One 3:e1732. 393 35. Wilson, I. A., and N. J. Cox. 1990. Structural basis of immune recognition of influenza 394 virus hemagglutinin. Annu Rev Immunol 8:737-771. 395 36. Xainli, J., J. L. Cole-Tobian, M. Baisor, W. Kastens, M. Bockarie, S. S. Yazdani, C. E. 396
Chitnis, J. H. Adams, and C. L. King. 2003. Epitope-specific humoral immunity to 397
Plasmodium vivax Duffy binding protein. Infect Immun 71:2508-2515. 398 37. Yazdani, S. S., A. R. Shakri, and C. E. Chitnis. 2004. A high cell density fermentation 399 strategy to produce recombinant malarial antigen in E. coli. Biotechnol Lett 26:1891-400 1895. 401
Table 1. Panel of DBPII alleles used for protein expression and COS 7 cell assay
DBPII Allele Accession # Amino Acid Residues
308 319 333 369 371 375 384 385 386 390 417 424 437 447 454 467 492 503 511 DBPII-Sal 1 P22290.2 R R L Y K N D E K R N L W S Q T K I V DBPII-O AAY79072.1 S . . . . . G . . H . I . K . . . . . DBPII-27.16 AAL79076 S . . . . . G . . H . I . K . . E . . DBPII-D AAG53621 S . . . . . G . . H . I . K . P . . . DBPII-7.18 AAL79051.1 S . . . . . G . Q . K I R . . . . K . DBPII-AH AAY34130.1 S . . . E . G . Q . K I R . . . . K . DBPII-E AAL79120.1 S K . . E . G . Q . K I R . K . . K . DBPII-C AAL79116 S . F D . . H K N . K I R . . . . K . DBPII-F AAC47185 . . . . E . G K N . K I . . . . . K L DBPII-P AAL79073.1 S . F . . D G K N H K I R . . . . K .
Polymorphic residues within DBPII and positions with reference to DBPII-Sal 1 (bold) are indicated. Conserved residues are